NCT02337270View on ClinicalTrials.gov

Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

September 7, 2021

Study Completion Date

September 7, 2021

Conditions

Tuberculosis

Interventions

BIOLOGICAL

Ad5Ag85A

Aerosol administration of Ad5Ag85A

Trial Locations (1)

L8N 3Z5

McMaster University Medical Centre, Hamilton

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McMaster University

OTHER

NCT02337270 - Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol | Biotech Hunter | Biotech Hunter